Blood-Based Test Could Help Identify Hard-to-Detect Gastrointestinal Cancers
A blood test that’s being developed to detect cancer at its earliest stages was roughly 90% effective at detecting gastrointestinal cancers, including... Read More
Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting
At ASCO GI, Leap Therapeutics announced that in a trial of DKN-01 in patients with advanced gastric cancer, elevated expression of DKK1... Read More
Association of Acupuncture and Acupressure With Improved Cancer Pain
A review of clinical trials reveals that acupuncture and acupressure help reduce pain and opioid usage in cancer patients.
BeiGene bags option on Leap cancer drug, requests PD-1 combination trial
BeiGene and Leap Therapeutics have teamed up to study a combination of an anti-DKK1 antibody with the anti-PD-1 antibody tislelizumab in patients... Read More
BeiGene bags option on Leap cancer drug, requests PD-1 combination trial
BeiGene and Leap Therapeutics have teamed up to study a combination of an anti-DKK1 antibody with the anti-PD-1 antibody tislelizumab in patients... Read More
Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor
Blueprint Medicines won FDA approval for Ayvakit (avapritinib), the first treatment for gastrointestinal stromal tumors (GISTs) that targets platelet-derived growth factor alpha... Read More
Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint
The new targeted drug Enhertu showed a promising response rate in a trial of patients with HER2-positive gastric cancer.
Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan
A Japanese study published in the journal Cancer reports that even moderate alcohol consumption raises the risk of cancer and that the... Read More
Gritstone posts ‘one of the most potent immunogenic-responses for a neoantigen vaccine’
Two patients with gastroesophageal cancer responded well to Gritstone Oncology’s immune-stimulating treatment in an early trial.
Cancer’s Addiction Could Be A Way to Defeat It
Researchers at the University of Melbourne created gastric cancer “organoids,” tiny replicas of diseased tissue, and used them to discover that a... Read More
